Hongjun Yuan

1.0k total citations
34 papers, 818 citations indexed

About

Hongjun Yuan is a scholar working on Hepatology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongjun Yuan has authored 34 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 11 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongjun Yuan's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Nanoplatforms for cancer theranostics (8 papers) and Renal cell carcinoma treatment (6 papers). Hongjun Yuan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Nanoplatforms for cancer theranostics (8 papers) and Renal cell carcinoma treatment (6 papers). Hongjun Yuan collaborates with scholars based in China, Russia and United States. Hongjun Yuan's co-authors include Fengyong Liu, Xueting Pan, Juan Guo, Weiwei Wang, Zhijun Huang, Chao Ni, Fengrong Zhang, Fengyong Liu, Wenjie Xia and Jing Tang and has published in prestigious journals such as Angewandte Chemie International Edition, Cancer Letters and Oncotarget.

In The Last Decade

Hongjun Yuan

33 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongjun Yuan China 15 365 220 171 145 141 34 818
Lingtong Meng China 13 378 1.0× 173 0.8× 139 0.8× 120 0.8× 74 0.5× 20 625
Yirun Li China 17 207 0.6× 309 1.4× 171 1.0× 173 1.2× 80 0.6× 28 728
Zhongqian Hu China 17 494 1.4× 294 1.3× 164 1.0× 159 1.1× 64 0.5× 31 839
Tiejun Zhou China 10 694 1.9× 282 1.3× 421 2.5× 105 0.7× 63 0.4× 26 1.1k
Bin Ji China 16 395 1.1× 252 1.1× 133 0.8× 152 1.0× 173 1.2× 60 1.0k
Meng-jun Qiu China 13 188 0.5× 174 0.8× 111 0.6× 65 0.4× 107 0.8× 28 535
Chunjuan Jiang China 14 251 0.7× 127 0.6× 79 0.5× 44 0.3× 189 1.3× 28 587
Liejing Lu China 19 412 1.1× 262 1.2× 199 1.2× 98 0.7× 50 0.4× 36 933
Qi Yue China 14 282 0.8× 270 1.2× 75 0.4× 51 0.4× 88 0.6× 32 776

Countries citing papers authored by Hongjun Yuan

Since Specialization
Citations

This map shows the geographic impact of Hongjun Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjun Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjun Yuan more than expected).

Fields of papers citing papers by Hongjun Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongjun Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjun Yuan. The network helps show where Hongjun Yuan may publish in the future.

Co-authorship network of co-authors of Hongjun Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Hongjun Yuan. A scholar is included among the top collaborators of Hongjun Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjun Yuan. Hongjun Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Hongjun, Hongli Yu, Wenjing Wang, et al.. (2025). Practice revolution in local interventional therapy for liver metastases. PubMed. 4(2). 100164–100164.
2.
Sun, Shanshan, Jiaxin Li, Wenwen Wang, et al.. (2024). Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing. Cancer Letters. 585. 216656–216656. 10 indexed citations
3.
Yuan, Hongjun, Jinhao Lyu, Yongqin Xiong, et al.. (2024). Resting‐state functional connectivity of the occipital cortex in different subtypes of Parkinson's disease. CNS Neuroscience & Therapeutics. 30(8). e14915–e14915. 3 indexed citations
4.
5.
Xia, Wenjie, Wuzhen Chen, Chao Ni, et al.. (2023). Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway. Breast Cancer Research. 25(1). 85–85. 28 indexed citations
6.
Liu, Fengyong, Ming Shi, Xin Li, et al.. (2022). MRI/PAI Dual-modal Imaging-guided Precise Tracking of Bone Marrow-derived Mesenchymal Stem Cells Labeled with Nanoparticles for Treating Liver Cirrhosis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations
7.
Yuan, Hongjun, et al.. (2021). Biocompatible copper sulfide–based nanocomposites for artery interventional chemo-photothermal therapy of orthotropic hepatocellular carcinoma. Materials Today Bio. 12. 100128–100128. 31 indexed citations
8.
Pan, Xueting, Weiwei Wang, Zhijun Huang, et al.. (2020). MOF‐Derived Double‐Layer Hollow Nanoparticles with Oxygen Generation Ability for Multimodal Imaging‐Guided Sonodynamic Therapy. Angewandte Chemie. 132(32). 13659–13663. 80 indexed citations
9.
10.
11.
Liu, Fengyong, et al.. (2019). A new management strategy for renal angiomyolipomas: superselective arterial embolization in combination with radiofrequency ablation. Annals of Translational Medicine. 7(23). 766–766. 2 indexed citations
12.
Yuan, Hongjun, et al.. (2019). Large hepatocellular carcinoma with local remnants after transarterial chemoembolization: treatment by sorafenib combined with radiofrequency ablation or sorafenib alone.. PubMed. 9(4). 791–799. 11 indexed citations
13.
Ye, Jun, Qingqing Fang, Yimin Shen, et al.. (2019). miR-4666-3p and miR-329 Synergistically Suppress the Stemness of Colorectal Cancer Cells via Targeting TGF-β/Smad Pathway. Frontiers in Oncology. 9. 1251–1251. 21 indexed citations
14.
Liu, Fengyong, Xin Li, Yangyang Li, et al.. (2019). Designing pH-triggered drug release iron oxide nanocomposites for MRI-guided photothermal-chemoembolization therapy of liver orthotopic cancer. Biomaterials Science. 7(5). 1842–1851. 16 indexed citations
15.
Yuan, Hongjun, et al.. (2018). Applications of nano-drug delivery systems in interventional-targeted for hepatocellular carcinoma: a review. Zhonghua gan-dan waike zazhi. 24(6). 427–430. 2 indexed citations
16.
Ni, Chao, et al.. (2018). Oncoplastic breast reconstruction with omental flap: A retrospective study and systematic review. Journal of Cancer. 9(10). 1782–1790. 18 indexed citations
17.
18.
19.
20.
Yang, Qiong, Zai‐yuan Ye, Qi Zhang, Zhong‐Sheng Zhao, & Hongjun Yuan. (2015). Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer. Tumor Biology. 37(1). 1189–1195. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingtong Meng Breakdown of academic impact, for papers by Yirun Li Breakdown of academic impact, for papers by Zhongqian Hu Breakdown of academic impact, for papers by Tiejun Zhou Breakdown of academic impact, for papers by Bin Ji Breakdown of academic impact, for papers by Meng-jun Qiu Breakdown of academic impact, for papers by Chunjuan Jiang Breakdown of academic impact, for papers by Liejing Lu Breakdown of academic impact, for papers by Qi Yue
Rankless by CCL
2026